Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2000-12-06
2004-05-11
Page, Thurman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C424S465000, C424S466000
Reexamination Certificate
active
06733781
ABSTRACT:
FIELD OF THE INVENTION
The current invention relates to tablets of low hardness but good physical stability, in particular fast dissolving tablets that can be made at very low compression force, yet have acceptable stability, and methods for preparing such tablets.
BACKGROUND OF THE INVENTION
Several processes are presently available by which a tablet, which dissolves quickly in the mouth, may be formulated. However, various disadvantages are associated with these currently available methods for producing fast dissolving tablets. For example the addition of high levels of disintegrants is disclosed by Cousin et al. (U.S. Pat. No. 5,464,632). Cousin et al. add two disintegrants to the disclosed tablet formulations, for example 16% starch 1500 and 13.3% crosspovidone. The oral-disintegration time of these tablets is 35 seconds to 45 seconds. However, tablets including high levels of disintegrants have a chalky or dry feel when placed in the mouth.
Another process for producing fast dissolving tablets involves freeze drying or lyophilizing solutions or suspensions of an active ingredient and matrix forming excipients. Pebley et al. (U.S. Pat. No. 5,298,261) disclose freeze-drying a slurry or paste comprising an active ingredient and excipients placed in blister packets. Humbert-Droz et al. (WO 97/36879) disclose vacuum drying, at room temperature or a slightly elevated temperature, a suspension including the active drug, a sugar alcohol, PEG 6000, talc, sweeteners and flavors in preformed blisters. The disadvantages of the freeze drying or vacuum drying methods are time (very slow process), cost of the equipment (not done on conventional tablet manufacturing equipment), and that it is limited to low dose actives.
Fast-dissolving tablets may also be formulated by the inclusion of effervescent coupled compounds. Wehling et al. (U.S. Pat. No. 5,178,878 and WO 91/04757) disclose the addition of an effervescent couple (such as sodium bicarbonate and citric acid) to a tablet. Exposure of the tablet to moisture results in contact and chemical reaction between the effervescent couple which leads to gas production and tablet disintegration. For this reason, tablets which include effervescent pairs are highly sensitive to moisture and have an unpleasant mouthfeel.
Tablets formed by compression under low compression force also dissolve more rapidly than tablets formed by high compression force. However, tablets produced by these processes have a high degree of friability. Crumbling and breakage of tablets prior to ingestion may lead to uncertainty as to the dosage of active ingredient per tablet. Furthermore, high friability also causes tablet breakage leading to waste during factory handling.
The present invention addresses these and other problems associated with the prior art. The invention provides fast-dissolving tablets of low hardness, low friability and high stability which have the added advantage of cost-effective methods of manufacture. In particular, the fast-dissolving tablets of the invention melt rapidly in the mouth and provide an excellent mouth feel.
SUMMARY OF THE INVENTION
The present invention advantageously provides compositions and methods for preparing a fast dissolving tablet of low hardness but good physical stability that can be made at very low compression force.
Thus, the invention provides a tablet comprising a low melting point compound that melts or softens at or below 37° C., a water soluble excipient, and an active ingredient. Preferably, the low melting point compound comprises from about 2.5% to about 20% (wt/wt) of the composition (e.g., 2.5, 5, 7.5, 10, 12, 14, 16, 18, or 20% (wt/wt)). Preferably the tablet has a hardness of about 3 kP or less, more preferably about 2 kP or less, and still more preferably about 1 kP or less. Preferably, the minimum hardness of the tablet is about 0.1 kP, although lower values, including 0.05 kP, are possible.
The invention further provides a method of producing a tablet composition. The method comprises combining an active agent (also termed “active ingredient” or “active”) with a fast dissolving granulation. The fast dissolving granulation comprises a low melting point compound and a water soluble excipient. Preferably, the low melting compound is present in an amount that will yield values of about 2.5% to about 20% (wt/wt) in a final tablet composition (e.g., 2.5, 5, 7.5, 10, 12, 14, 16, 18, or 20% (wt/wt)).
The accompanying Detailed Description, Examples and Drawings further elaborate the invention and its advantages.
REFERENCES:
patent: 5178878 (1993-01-01), Wehling et al.
patent: 5298261 (1994-03-01), Pebley
patent: 5464632 (1995-11-01), Cousin et al.
patent: 5576014 (1996-11-01), Mizumoto et al.
patent: 5609883 (1997-03-01), Valentine
patent: 5728403 (1998-03-01), Mauger et al.
patent: 5762961 (1998-06-01), Roser
patent: 5807577 (1998-09-01), Ouali
patent: 5807578 (1998-09-01), Acosta-Cuello et al.
patent: 5837285 (1998-11-01), Nakamichi et al.
patent: 5837292 (1998-11-01), Dijkgraaf
patent: 5853758 (1998-12-01), Lo
patent: 5939091 (1999-08-01), Eoga
patent: 0345528 (1989-05-01), None
patent: 0345528 (1992-12-01), None
patent: 0553777 (1993-01-01), None
patent: 0345628 (1993-05-01), None
patent: 0553777 (1993-08-01), None
patent: 0 922 464 (1999-06-01), None
patent: 0922464 (1999-06-01), None
patent: 0 947 198 (1999-10-01), None
patent: 0 960 621 (1999-12-01), None
patent: 11-35451 (1999-02-01), None
patent: 11-035451 (1999-02-01), None
patent: WO91/04757 (1991-04-01), None
patent: 91/04757 (1991-04-01), None
patent: WO97/38679 (1997-04-01), None
patent: WO97/18796 (1997-05-01), None
patent: 97/18796 (1997-05-01), None
patent: WO 97/38679 (1997-10-01), None
patent: 97/38679 (1997-10-01), None
patent: 98/10762 (1998-03-01), None
patent: WO98/52541 (1998-05-01), None
patent: 98/46215 (1998-10-01), None
patent: WO98/46215 (1998-10-01), None
patent: 98/52541 (1998-11-01), None
patent: WO99/44580 (1999-03-01), None
patent: 99/44580 (1999-10-01), None
Aveka Group http://www.thomasregister.com/olc/aveka/prilling.htm, (May 10, 2000) “Prilling”.*
Maejima et al., Preparation of Spherical Beads Without Any Use of Solvents by a Novel Tumbling Melt Granulation (TMG) Method, Chem. Pharm. Bull. 45(3), 518-524 (1997).*
Grunhagen, H. and Muller, O., “Melt Extrusion Technology,” Pharmaceutical Manufacturing International, 1995, p. 165-170.
Schaefer, et al., Drug Development and Industrial Pharmacy, 16(8), 1249-1277 (1990).
Voinovich, et al., “Screening of High Shear Mixer Melt Granulation Process Variables Using an Asymmetrical Factorial Design,” International Journal of Pharmaceutics, 190, 73-81 (1999).
Breitenbach, Jorg, “Melt-Extrusion: An Innovative Technology For Tablet Manufacture,” 6thPharm Tech Europe Conference, p. (13) 8-18, (1998).
Buckton, Graham, et al., “The use of isothermal microcalorimetry in the study of changes in crystallinity of spray-dried salbutamol sulphate,” International Journal of Pharmaceutics, 1995, 116: 113-118.
Screening of high shear mixer melt granulation process variables using an asymmetrical factorial design, Voinovich,D., et al., International Journal of Pharmaceutics 190:73-81, 1999.
Melt Granulation in a Laboratory Scale High Shear Mixer, Schaefer, T., et al., Drug Development and Industrial Pharmacy 16(8): 1249-1277, 1990.
Preparation of Spherical Beads without Any Use of Solvents by a Novel Tumbling Melt Granulation (TMG) Method, Maejima, T., et al., Chem. Pharm. Bull. 45(3):518-524, 1997.
Abu-Izza Khawla A.
Li Vincent H.
Look Jee L.
Parr Graham D.
Schineller Matthew K.
Darby & Darby
Page Thurman K.
Sheikh Humera N.
Wyeth
LandOfFree
Fast dissolving tablet does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fast dissolving tablet, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fast dissolving tablet will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3229917